scispace - formally typeset
E

Elizabeth A. Maher

Researcher at University of Texas Southwestern Medical Center

Publications -  94
Citations -  12511

Elizabeth A. Maher is an academic researcher from University of Texas Southwestern Medical Center. The author has contributed to research in topics: Glioma & Cancer. The author has an hindex of 39, co-authored 89 publications receiving 10966 citations. Previous affiliations of Elizabeth A. Maher include Harvard University.

Papers
More filters
Journal ArticleDOI

The landscape of somatic copy-number alteration across human cancers

Rameen Beroukhim, +86 more
- 18 Feb 2010 - 
TL;DR: It is demonstrated that cancer cells containing amplifications surrounding the MCL1 and BCL2L1 anti-apoptotic genes depend on the expression of these genes for survival, and a large majority of SCNAs identified in individual cancer types are present in several cancer types.
Journal ArticleDOI

Malignant glioma: Genetics and biology of a grave matter

TL;DR: Although a comprehensive view of the genetic lesions encountered in malignant gliomas has been compiled, substantive conceptual and practical barriers remain in assigning functional significance to these genetic changes and in harnessing this basic information into the development of drugs that make a difference in patient care.
Journal ArticleDOI

Epidermal growth factor receptor and Ink4a/Arf: convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis.

TL;DR: These data support the view that dysregulation of specific genetic pathways, rather than cell-of-origin, dictates the emergence and phenotype of high-grade gliomas and provide evidence that p16(INK4a) and p19(ARF) synergize to maintain terminal astrocyte differentiation.
Journal ArticleDOI

Acetate Is a Bioenergetic Substrate for Human Glioblastoma and Brain Metastases

TL;DR: The data demonstrate a strikingly common metabolic phenotype in diverse brain tumors that includes the ability to oxidize acetate in the citric acid cycle, which may be important for meeting the high biosynthetic and bioenergetic demands of malignant growth.